Sign In
Buy LH
$309.20
-6.33 (-2.01%)
At Close: Jul 31, 2026
A Trio of High Return Non-Cyclical Stocks for the Value Investor
11:48am, Thursday, 20'th May 2021
If seeking for high return investments amid non-cyclical stocks, investors could be interested in the three companies listed below, as their earnings yields (as calculated via Joel Greenblatt ( Joel G
LabCorp's (LH) New Bioanalytical Lab to Boost APAC Operation
10:32am, Thursday, 20'th May 2021
The new laboratory by LabCorp (LH) is set to enable faster data turnaround for early phase trials in Asia-Pacific markets.
Labcorp to Expand Bioanalytical Services With Integrated Laboratory in Singapore
05:54pm, Wednesday, 19'th May 2021
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced the expansion of its drug development offering in the Asia-Pacific region with the additi
LabCorp's (LH) Pixel Kit Gets EUA for Younger Population
10:31am, Tuesday, 18'th May 2021
LabCorp (LH) becomes the first major commercial laboratory to offer a COVID-19 PCR Test Home Collection Kit for children and adolescents.
Labcorp Prices $500,000,000 in 1.550% Senior Notes Due 2026 and $500,000,000 in 2.700% Senior Notes Due 2031
08:14pm, Wednesday, 12'th May 2021
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH) (“Labcorp”) announced today that it has priced its offering of $1,000,000,000 in senior notes. The offering consists of two tranches: $500,000
Labcorp and the U.S. Department of Health and Human Services Join Forces to Raise Awareness of COVID-19 Treatments
04:18pm, Tuesday, 11'th May 2021
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, is working with the U.S. Department of Health and Human Services (HHS) to raise awareness of potentially
LabCorp (LH) Base Line Growth Solid, COVID-Related Sales Drop
11:39am, Wednesday, 05'th May 2021
LabCorp's (LH) Walgreens-partnership expands to include new integrated digital experiences.
4 Medical Products Stocks Set to Beat This Earnings Season
12:02pm, Tuesday, 04'th May 2021
Rebound in base sales make us optimistic about OMI, INGN, XRAY and CNTG's results this time around.
Test Available Exclusively through Labcorp in the U.S. and Canada
Laboratory Corporation of America Holdings (LH) CEO Adam Schechter on Q1 2021 Results - Earnings Call Transcript
02:59pm, Thursday, 29'th Apr 2021
Laboratory Corporation of America Holdings (LH) CEO Adam Schechter on Q1 2021 Results - Earnings Call Transcript
LabCorp (LH) Q1 Earnings Surpass Estimates, View Raised
12:47pm, Thursday, 29'th Apr 2021
LabCorp's (LH) raises 2021 guidance but projects significant sinking of COVID-related testing revenues.
LabCorp (LH) Tops Q1 Earnings and Revenue Estimates
09:01am, Thursday, 29'th Apr 2021
LabCorp (LH) delivered earnings and revenue surprises of 20.08% and 7.39%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Why Earnings Season Could Be Great for LabCorp (LH)
09:17am, Wednesday, 28'th Apr 2021
LabCorp (LH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
LabCorp (LH) to Report Q1 Earnings: What's in the Offing?
09:01am, Friday, 23'rd Apr 2021
With respect to LabCorp's (LH) COVID-19 testing services wing, although extensive vaccine rollouts are ongoing, the resurgence of the virus might have once again boosted testing demand in Q1.
Laboratory Corporation Of America Holdings: Valuations, Fundamentals Make Shares Attractive
10:34am, Wednesday, 21'st Apr 2021
Laboratory Corporation of America Holdings shares currently look attractive on fundamental momentum and valuations. Shares come in at 19x FWD FCF and trade at average -21% discount to peer median acro
